The Anticancer Effects of MPT0G211, a Novel HDAC6 Inhibitor, Combined With Chemotherapeutic Agents in Human Acute Leukemia Cells
Clinical Epigenetics - Germany
doi 10.1186/s13148-018-0595-8
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2018
Authors
Publisher
Springer Science and Business Media LLC